title: Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders.
abstract: The prefrontal cortex (PFC) elaborates and differentiates in primates, and there is a corresponding elaboration in cortical dopamine (DA). DA cells that fire to both aversive and rewarding stimuli likely project to the dorsolateral PFC (dlPFC), signaling a salient event. Since 1979, we have known that DA has an essential influence on dlPFC working memory functions. DA has differing effects via D1 (D1R) versus D2 receptor (D2R) families. D1R are concentrated on dendritic spines, and D1/5R stimulation produces an inverted U-shaped dose response on visuospatial working memory performance and Delay cell firing, the neurons that generate representations of visual space. Optimal levels of D1R stimulation gate out "noise," whereas higher levels, e.g., during stress, suppress Delay cell firing. These effects likely involve hyperpolarization-activated cyclic nucleotide-gated channel opening, activation of GABA interneurons, and reduced glutamate release. Dysregulation of D1R has been related to cognitive deficits in schizophrenia, and there is a need for new, lower-affinity D1R agonists that may better mimic endogenous DA to enhance mental representations and improve cognition. In contrast to D1R, D2R are primarily localized on layer V pyramidal cell dendrites, and D2/3R stimulation speeds and magnifies the firing of Response cells, including Response Feedback cells. Altered firing of Feedback neurons may relate to positive symptoms in schizophrenia. Emerging research suggests that DA may have similar effects in the ventrolateral PFC and frontal eye fields. Research on the orbital PFC in monkeys is just beginning and could be a key area for future discoveries.
authors.affiliation: Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut amy.arnsten@yale.edu.
authors.forename: Amy F T
authors.initials: AF
authors.lastname: Arnsten
authors.affiliation: Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Min
authors.initials: M
authors.lastname: Wang
authors.affiliation: Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Constantinos D
authors.initials: CD
authors.lastname: Paspalas
mesh_terms: D000818:Animals; D003072:Cognition Disorders / Q000188:drug therapy* / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism*; D018491:Dopamine Agonists / Q000494:pharmacology; D015195:Drug Design; D006801:Humans; D008570:Memory, Short-Term / Q000502:physiology; D017397:Prefrontal Cortex / Q000378:metabolism* / Q000503:physiopathology; D011323:Primates; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D018491:Dopamine Agonists; D011954:Receptors, Dopamine; D004298:Dopamine